Galectin Therapeutics logo
Galectin Therapeutics GALT
$ 2.74 -2.66%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Galectin Therapeutics EV/EBITDA Ratio 2011-2024 | GALT

Annual EV/EBITDA Ratio Galectin Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-1.92 -3.61 -6.75 -13.7 -10.2 -0.645 -0.407 -2.67 -17.1 -3.11 -4.99

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-0.407 -17.1 -5.92